z-logo
open-access-imgOpen Access
Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation
Author(s) -
Dezhi Li,
Qian Liu,
Feng Zhang,
Qi Zhang,
Saran Feng
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000011157
Subject(s) - medicine , polyuria , polydipsia , nephrogenic diabetes insipidus , diabetes insipidus , transplantation , surgery , gastroenterology , diabetes mellitus , endocrinology
Rationale: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. Patient concerns: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. Diagnoses: NDI was diagnosed with insignificant response to a water deprivation test after stimulation with vasopressin injection. Bone marrow examination combined with immunophenotypic analysis, cerebrospinal cytology, and abdominal ultrasonography confirmed the diagnoses of precursor B cell ALL with renal infiltration. Interventions: The patient accepted standardized combination chemotherapy and ultimately had sustained remission, and his polydipsia and polyuria disappeared after 3 days of treatment. The ALL relapsed 1 year later and he received haploidentical stem cell transplantation (haplo-SCT) from his father. Outcomes: One year later, he again developed NDI, with bilateral renal enlargement because of extramedullary relapse, leading to subsequent death. Lessons: This case demonstrates unusual early renal involvement in ALL presenting with initial NDI. Interestingly, the NDI returned with the relapse of renal infiltration 1 year after haplo-SCT. This case suggests that NDI was probably secondary to renal leukemic infiltration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here